In another similar study, it was postulated that wogonin can reverse multidrug resistance in CRC based on inhibiting HIF‐1, glycolysis, and the PI3K/Akt signaling pathway both in vivo and in vitro (Zhan et al. 2023). This evidence concerns the gene HIF1A and colorectal carcinoma.